login
  Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

Implantable cardioverter defibrillators in patients nearing the end of life


Monday, 23 Apr 2012 14:02
Rachel Lampert
Rachel Lampert


Rachel Lampert, associate professor of Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, USA, is giving the talk “When to consider ICD deactivation: End-of-life issues” at Heart Rhythm 2012 (9–12 May 2012, Boston, USA). She talked to Cardiac Rhythm News about this topic.


When would you consider deactivating an implantable cardioverter defibrillator (ICD) in a patient who was nearing the end of their life?

The short answer is that ICD deactivation should be considered whenever a patient wants it to be considered. Even if a patient was not near the end of their life, legally and ethically, an ICD should be deactivated if the patient wants it to be deactivated.

However, the longer answer is that all patients with an ICD should have an opportunity to discuss the option of deactivation before they reach the end of their life (ie, shortly after implantation). The issue of deactivation should also be proactively discussed with a patient when their condition worsens and a good time to discuss the issue is when other preferences, such advanced directives [living wills] or a do not resuscitate (DNR) orders, are being discussed. It is not up to the physician when an ICD “should” be deactivated. The role of the physician is to make sure the patient understands the consequences of keeping it active versus deactivating it—when the patient has all of the available facts, then the decision to deactivate is up to them. The decision should be made in the context of the person’s overall goals for his or her care at that time.


What are the indications that a patient is nearing the end of their life?


Often it is not clear, and this is one of the difficult issues in discussing deactivation and one of the reasons it is so important to discuss the issue early on. Other times, though, physicians can tell as a patient’s disease course progresses (whether it is their underlying heart disease or another disease such as cancer) that the disease is overcoming the patient and therapeutic options are exhausted.


You state that a good time to discuss deactivation is when advance healthcare directives are being discussed. Would you therefore encourage patients to include their wishes on ICD deactivation in these documents and generally why in your view are such directives important?


I would definitely encourage patients to write an advanced directive, and that they include their wishes regarding ICD deactivation. This is important, as is all advanced planning relating to ICD deactivation at the end of life, to avoid potential shocks, which are painful, as a person is dying.


If a healthcare provider has ethical or moral concerns about deactivation, what should they do?


The American Medical Association (AMA) code of ethics states that a physician should not be compelled to perform an action that goes against his moral beliefs. However, our document (1) stresses that the healthcare provider should not attempt to impose his beliefs on the patient and should help direct the patient to an alternate provider who can help him.


References

1. Lampert et al. Heart Rhythm Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing the end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7:1008–26




Add New Comment

Most popular


Friday, 18 Jul 2014
Even in moderation, consumption of wine and hard liquor may be a risk factor for atrial fibrillation, according to new research recently published in the Journal of the American College of Cardiology.... Moderate alcohol use associated with increased risk for atrial fibrillation

Physicians implant world's first ProMRI Quadripolar CRT-D system to treat heart failure
Tuesday, 15 Jul 2014
With Sentus quadripolar leads and the Inventra series, Biotronik offers the only devices for patients with heart failure worldwide that are approved for MRI use. Physicians implant world's first ProMRI Quadripolar CRT-D system to treat heart failure

FDA approves Attain Performa quadripolar lead and Viva Quad CRT-Ds
Thursday, 07 Aug 2014
Medtronic has received US Food and Drug Administration (FDA) approval for the Attain Performa Model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronisation therapy ... FDA approves Attain Performa quadripolar lead and Viva Quad CRT-Ds

Features


A biological pacemaker is on its way
Wednesday, 13 Aug 2014
After over 10 years of research, scientists in the United States have demonstrated—for the first time—the feasibility of a somatic cell reprogramming strategy for creating a biological pacemaker in a ... A biological pacemaker is on its way

Sports for young patients with implantable cardioverter defibrillators: Refining the risk
Wednesday, 13 Aug 2014
Elizabeth Saarel (University of Utah, Salt Lake City, USA) argues that, based on prospective registry data, young patients with implantable cardioverter defibrillators can participate safely in ... Sports for young patients with implantable cardioverter defibrillators: Refining the risk

Profiles


Nick Linker
Monday, 14 Jul 2014
Nick Linker is president-elect of the British Heart Rhythm Society (BHRS) and programme director of ... Nick Linker

Richard Fogel
Thursday, 08 May 2014
Richard Fogel, president-elect of the Heart Rhythm Society and chief executive officer at St V... Richard Fogel

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions